Ligand Pharma (LGND) Tops Q2 EPS by 29c
Tweet
Share
E-mailGet Alerts LGND Hot Sheet
Price: $286.44 -0.33%
Financial Fact:
Weighted average number of common shares - basic: 20.89M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Weighted average number of common shares - basic: 20.89M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Ligand Pharma (NASDAQ: LGND) reported Q2 EPS of $1.63, $0.29 better than the analyst estimate of $1.34. Revenue for the quarter came in at $54.7 million versus the consensus estimate of $70.41 million.
For earnings history and earnings-related data on Ligand Pharma (LGND) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- UBS says bull market has further to run
- BMO starts chip stocks coverage: Here are its preferred picks
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
